According to a report in Kommersant on August 20, the Russian Ministry of Internal Affairs (MVD Rossii) has proposed adding 18 psychoactive substances to a controlled list, primarily due to the risk of abuse among drug users.
These substances include nine synthetic and natural cannabinoids, four types of opioids, four types of benzodiazepines, and one phenethylamine compound.
The proposal has been published on the regulatory draft portal website. According to the explanation provided in the proposal, the Ministry of Internal Affairs suggests adding these substances to the list of controlled substances under Category I (prohibited from circulation in Russia) and Category III (allowing exemptions for certain control measures).
The proposal was put forward due to the appearance of e-cigarette liquids and food products containing cannabis ingredients in the European market.
The proposal also includes suggestions for amending Article 228 (drug trafficking) and Article 229 (theft of psychoactive substances) of the Russian Criminal Code.
This proposal aims to further combat the distribution and abuse of drugs, ensuring public health and social safety.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
